{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:44:22Z","timestamp":1790444662464,"version":"4.1.0"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"DOI":"10.13039\/100009339","name":"Steadman Philippon Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Injectable peptides are increasingly promoted for musculoskeletal recovery, tissue repair, and performance enhancements; however, clinical adoption has outpaced high-quality evidence and regulatory consensus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To summarize contemporary human and translational evidence (January 1, 2020-August 31, 2025) for injectable peptides relevant to orthopaedics and sports medicine, and to clarify safety, product quality, regulatory, antidoping implications, and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design:<\/jats:title>\n                    <jats:p>Structured narrative review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>PubMed\/MEDLINE, Embase, and Web of Science were searched (January 1, 2020-August 31, 2025). Eligible studies included randomized controlled trials, prospective human studies, and translational investigations directly applicable to musculoskeletal care; noninjectable formulations and nonmusculoskeletal indications were excluded. Results were synthesized qualitatively; risk of bias for human trials was appraised using standard tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Five functional peptide classes were identified. Glucagon-like peptide-1 receptor agonists (e.g., semaglutide) are the only class supported by reproducible randomized evidence of symptomatic improvement in knee osteoarthritis, with benefits primarily mediated by clinically meaningful weight loss and putative anti-inflammatory effects, whereas structural cartilage modification remains unproven. Collagen-derived injectable preparations show preliminary postoperative symptom\/early recovery benefits in small, single-center prospective human studies. Regenerative peptides (e.g., body protection compound-157 and thymosin derivatives) and growth hormone axis secretagogues (e.g., CJC-1295, ipamorelin, and tesamorelin) remain investigational, with uncertain safety profiles, product quality concerns, and widespread antidoping restrictions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Injectable peptides for sports medicine remain largely experimental. Clinical use should be confined to approved metabolic agents for indicated conditions and to rigorously designed research protocols. Clinicians caring for athletes must counsel patients regarding uncertain efficacy, product quality, safety risks, and antidoping implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      <jats:underline>Level V<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strength of Recommendation Taxonomy:<\/jats:title>\n                    <jats:p>Predominantly C.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.rvw.26.00027","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:01:07Z","timestamp":1779300067000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications"],"prefix":"10.2106","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1187-9559","authenticated-orcid":false,"given":"Alan D.","family":"Villegas Meza","sequence":"first","affiliation":[{"name":"The Steadman Philippon Research Institute, Vail, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2843-7327","authenticated-orcid":false,"given":"Michael","family":"Nocek","sequence":"additional","affiliation":[{"name":"The Steadman Philippon Research Institute, Vail, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-7569","authenticated-orcid":false,"given":"Brendon C.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"The Steadman Philippon Research Institute, Vail, Colorado"},{"name":"The Steadman Clinic, Vail, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1799-0046","authenticated-orcid":false,"given":"Miguel","family":"Lizarraga","sequence":"additional","affiliation":[{"name":"University of California, San Francisco School of Medicine, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3164-1615","authenticated-orcid":false,"given":"Mikalyn T.","family":"DeFoor","sequence":"additional","affiliation":[{"name":"The Steadman Philippon Research Institute, Vail, Colorado"},{"name":"The Steadman Clinic, Vail, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1892-3378","authenticated-orcid":false,"given":"Joseph J.","family":"Ruzbarsky","sequence":"additional","affiliation":[{"name":"The Steadman Philippon Research Institute, Vail, Colorado"},{"name":"The Steadman Clinic, Vail, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3935-8803","authenticated-orcid":false,"given":"Johnny","family":"Huard","sequence":"additional","affiliation":[{"name":"The Steadman Philippon Research Institute, Vail, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0358-3331","authenticated-orcid":false,"given":"Marc J.","family":"Philippon","sequence":"additional","affiliation":[{"name":"The Steadman Philippon Research Institute, Vail, Colorado"},{"name":"The Steadman Clinic, Vail, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5]]},"reference":[{"issue":"11","key":"r1-20260520","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.3390\/nu13113997","article-title":"Potential relevance of bioactive peptides in sports nutrition","volume":"13","author":"K\u00f6nig","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"r2-20260520","doi-asserted-by":"crossref","first-page":"399","DOI":"10.59249\/TKNM3388","article-title":"Local and systemic peptide therapies for soft tissue regeneration: a narrative review","volume":"97","author":"Cushman","year":"2024","journal-title":"Yale J Biol Med"},{"issue":"6","key":"r3-20260520","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/jcm14062061","article-title":"Advancements in regenerative therapies for orthopedics: a comprehensive review of platelet-rich plasma, mesenchymal stem cells, peptide therapies, and biomimetic applications","volume":"14","author":"Goulian","year":"2025","journal-title":"J Clin Med"},{"issue":"10","key":"r4-20260520","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.arthro.2025.05.001","article-title":"Editorial commentary: digital internet information on orthobiologic treatments is low quality, misleading, and unreliable","volume":"41","author":"Olsen","year":"2025","journal-title":"Arthroscopy"},{"issue":"4","key":"r5-20260520","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.csm.2024.10.011","article-title":"Economic realities of orthobiologics","volume":"44","author":"Sachs","year":"2025","journal-title":"Clin Sports Med"},{"issue":"1","key":"r6-20260520","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pmr.2022.08.016","article-title":"Regulatory considerations of orthobiologic procedures","volume":"34","author":"Jang","year":"2023","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"2","key":"r7-20260520","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00441-019-03016-8","article-title":"Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing","volume":"377","author":"Gwyer","year":"2019","journal-title":"Cell Tissue Res"},{"issue":"3","key":"r8-20260520","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/phar.70005","article-title":"The potential role of GLP-1 receptor agonists in osteoarthritis","volume":"45","author":"Ryan","year":"2025","journal-title":"Pharmacotherapy"},{"issue":"11","key":"r9-20260520","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41584-025-01302-0","article-title":"Glucagon-like peptide-1 receptor agonists in arthritis: current insights and future directions","volume":"21","author":"Karacabeyli","year":"2025","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"r10-20260520","first-page":"847","article-title":"A phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients","volume":"43","author":"Yazici","year":"2025","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"r11-20260520","first-page":"854","article-title":"Phase 3, 56-week, randomised, double-blind, placebo-controlled study utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis: OA-11 study","volume":"43","author":"Yazici","year":"2025","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"r12-20260520","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/art.41315","article-title":"Lorecivivint, a novel intraarticular CDC-like kinase 2 and dual-specificity tyrosine phosphorylation-regulated kinase 1A inhibitor and Wnt pathway modulator for the treatment of knee osteoarthritis: a phase II randomized trial","volume":"72","author":"Yazici","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"r13-20260520","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.1021\/acsami.4c18221","article-title":"Nanoengineered self-assembling peptides with increased proteolytic stability promote wound healing","volume":"17","author":"Castro","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"r14-20260520","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1523-1747.2000.00166.x","article-title":"Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+)","volume":"115","author":"Sim\u00e9on","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"2","key":"r15-20260520","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.arthro.2024.09.005","article-title":"Injectable therapeutic peptides: an adjunct to regenerative medicine and sports performance?","volume":"41","author":"DeFoor","year":"2025","journal-title":"Arthroscopy"},{"issue":"2","key":"r16-20260520","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/ph18020185","article-title":"Multifunctionality and possible medical application of the BPC 157 peptide-literature and patent review","volume":"18","author":"J\u00f3zwiak","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"12","key":"r17-20260520","first-page":"759","article-title":"Off-label use and misuse of hormone supplements: AACE and ACE position statement","volume":"102","author":"Arnold","year":"2020","journal-title":"Am Fam Physician"},{"issue":"1","key":"r18-20260520","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11033-025-10304-w","article-title":"Growth hormone signaling and clinical implications: from molecular to therapeutic perspectives","volume":"52","author":"Aghili","year":"2025","journal-title":"Mol Biol Rep"},{"issue":"17","key":"r19-20260520","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","article-title":"Once-weekly semaglutide in persons with obesity and knee osteoarthritis","volume":"391","author":"Bliddal","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"r20-20260520","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.joca.2021.02.004","article-title":"A phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2\/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis","volume":"29","author":"Yazici","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"r21-20260520","doi-asserted-by":"crossref","first-page":"e70158","DOI":"10.1002\/jeo2.70158","article-title":"Post\u2010operative injection of hydrolyzed collagen peptides shows anti\u2010inflammatory effect in patients with femoroacetabular impingement improving the early recovery","volume":"12","author":"Tassinari","year":"2025","journal-title":"J Exp Orthop"},{"issue":"2","key":"r22-20260520","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.52768\/2833-5465\/1127","article-title":"Effectiveness of hydrolyzed collagen peptide injection for the treatment of collateral ligament pain: a randomized controlled trial","volume":"3","author":"Thi","year":"2023","journal-title":"J Clin Med Surg"},{"issue":"8","key":"r23-20260520","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1177\/0363546520920591","article-title":"The use of recombinant human growth hormone to protect against muscle weakness in patients undergoing anterior cruciate ligament reconstruction: a pilot, randomized placebo-controlled trial","volume":"48","author":"Mendias","year":"2020","journal-title":"Am J Sports Med"},{"issue":"10","key":"r24-20260520","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s00125-023-05929-0","article-title":"Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy","volume":"66","author":"Tsch\u00f6p","year":"2023","journal-title":"Diabetologia"},{"issue":"8","key":"r25-20260520","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","article-title":"GLP-1-based therapies for diabetes, obesity and beyond","volume":"24","author":"Drucker","year":"2025","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"r26-20260520","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41598-022-05323-7","article-title":"Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis","volume":"12","author":"Meurot","year":"2022","journal-title":"Sci Rep"},{"issue":"21","key":"r27-20260520","doi-asserted-by":"crossref","first-page":"e194751","DOI":"10.1172\/JCI194751","article-title":"Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits","volume":"135","author":"Wong","year":"2025","journal-title":"J Clin Invest"},{"key":"r28-20260520","doi-asserted-by":"crossref","first-page":"1627691","DOI":"10.3389\/fphar.2025.1627691","article-title":"Emerging therapeutic potential of glucagon-like Peptide-1 receptor agonists in knee osteoarthritis: a systematic review","volume":"16","author":"Li","year":"2025","journal-title":"Front Pharmacol"},{"issue":"2","key":"r29-20260520","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12020-025-04179-x","article-title":"Effect of semaglutide with obesity or overweight individuals without diabetes: an umbrella review of systematic reviews","volume":"88","author":"Hu","year":"2025","journal-title":"Endocrine"},{"issue":"9","key":"r30-20260520","doi-asserted-by":"crossref","first-page":"103864","DOI":"10.1016\/j.autrev.2025.103864","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists in rheumatology: a review of current evidence and future directions","volume":"24","author":"Bilgin","year":"2025","journal-title":"Autoimmun Rev"},{"issue":"12","key":"r31-20260520","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1080\/13543784.2020.1842357","article-title":"Lorecivivint, an intra-articular potential disease-modifying osteoarthritis drug","volume":"29","author":"Sabha","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"issue":"10472","key":"r32-20260520","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(24)02322-5","article-title":"Osteoarthritis","volume":"405","author":"Kloppenburg","year":"2025","journal-title":"Lancet"},{"issue":"9","key":"r33-20260520","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.joca.2019.05.006","article-title":"Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment","volume":"27","author":"Deshmukh","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"r34-20260520","doi-asserted-by":"crossref","first-page":"1181619","DOI":"10.3389\/fcell.2023.1181619","article-title":"Role of Wnt signaling pathway in joint development and cartilage degeneration","volume":"11","author":"Li","year":"2023","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"r35-20260520","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/rheumatology\/keae610","article-title":"Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials","volume":"64","author":"Tambiah","year":"2025","journal-title":"Rheumatology"},{"issue":"16","key":"r36-20260520","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.2023.19675","article-title":"Evaluation and treatment of knee pain: a review","volume":"330","author":"Duong","year":"2023","journal-title":"JAMA"},{"issue":"11","key":"r37-20260520","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.joca.2025.08.015","article-title":"Osteoarthritis year in review 2025: epidemiology and therapy","volume":"33","author":"Dell'Isola","year":"2025","journal-title":"Osteoarthritis Cartilage"},{"issue":"5","key":"r38-20260520","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.3390\/ijerph20054390","article-title":"Intra-articular collagen injections for osteoarthritis: a narrative review","volume":"20","author":"Tarantino","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"17","key":"r39-20260520","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.3390\/jcm14176058","article-title":"Injectable porcine collagen in musculoskeletal disorders: a Delphi consensus","volume":"14","author":"De Lucia","year":"2025","journal-title":"J Clin Med"},{"issue":"15","key":"r40-20260520","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.3390\/molecules30153061","article-title":"Progress in research on animal collagen peptides: preparation, bioactivity, and application","volume":"30","author":"Ma","year":"2025","journal-title":"Molecules"},{"issue":"4","key":"r41-20260520","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/polym15041020","article-title":"An update on the clinical efficacy and safety of collagen injectables for aesthetic and regenerative medicine applications","volume":"15","author":"Salvatore","year":"2023","journal-title":"Polymers"},{"issue":"12","key":"r42-20260520","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1007\/s00167-023-07624-4","article-title":"Orthobiologics as an adjunct in treatment of femoroacetabular impingement syndrome: cell-based therapies facilitate improved postoperative outcomes in the setting of acetabular chondral lesions: a systematic review","volume":"31","author":"George","year":"2023","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"4","key":"r43-20260520","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.arthro.2024.04.028","article-title":"Autologous matrix-induced chondrogenesis for the treatment of hip acetabular chondral lesions demonstrates improved patient reported outcomes and low rates of secondary surgeries at short-term follow-up: a systematic review","volume":"41","author":"Mahatme","year":"2025","journal-title":"Arthroscopy"},{"key":"r44-20260520","doi-asserted-by":"crossref","first-page":"648108","DOI":"10.1155\/2015\/648108","article-title":"GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration","volume":"2015","author":"Pickart","year":"2015","journal-title":"BioMed Res Int"},{"issue":"1","key":"r45-20260520","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/molecules30010136","article-title":"Are we ready to measure skin permeation of modern antiaging GHK-Cu tripeptide encapsulated in liposomes?","volume":"30","author":"Og\u00f3rek","year":"2025","journal-title":"Molecules"},{"issue":"5","key":"r46-20260520","doi-asserted-by":"crossref","first-page":"C770","DOI":"10.1152\/ajpcell.00263.2021","article-title":"Discovery of thymosin \u03b24 as a human exerkine and growth factor","volume":"321","author":"Gonzalez-Franquesa","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"r47-20260520","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/jor.22831","article-title":"Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction","volume":"33","author":"Fu","year":"2015","journal-title":"J Orthop Res"},{"key":"r48-20260520","doi-asserted-by":"crossref","first-page":"111660","DOI":"10.1016\/j.msec.2020.111660","article-title":"Enhanced angiogenic effects of RGD, GHK peptides and copper (II) compositions in synthetic cryogel ECM model","volume":"120","author":"Zoughaib","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"2","key":"r49-20260520","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/wrr.12520","article-title":"GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis","volume":"25","author":"Wang","year":"2017","journal-title":"Wound Repair Regen"},{"issue":"pt 1","key":"r50-20260520","doi-asserted-by":"crossref","first-page":"114982","DOI":"10.1016\/j.colsurfb.2025.114982","article-title":"An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-inflammatory and antioxidant","volume":"256","author":"Hu","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"10","key":"r51-20260520","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/pharmaceutics15102485","article-title":"Liposomes as carriers of GHK-Cu tripeptide for cosmetic application","volume":"15","author":"Dymek","year":"2023","journal-title":"Pharmaceutics"},{"key":"r52-20260520","doi-asserted-by":"crossref","first-page":"627533","DOI":"10.3389\/fphar.2021.627533","article-title":"Stable gastric pentadecapeptide BPC 157 and wound healing","volume":"12","author":"Seiwerth","year":"2021","journal-title":"Front Pharmacol"},{"issue":"12","key":"r53-20260520","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.3390\/biomedicines10123221","article-title":"Stable gastric pentadecapeptide BPC 157 and striated, smooth, and heart muscle","volume":"10","author":"Staresinic","year":"2022","journal-title":"Biomedicines"},{"issue":"8","key":"r54-20260520","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3390\/pharmaceutics14081684","article-title":"Practical considerations for translating mesenchymal stromal cell-derived extracellular vesicles from bench to bed","volume":"14","author":"Lui","year":"2022","journal-title":"Pharmaceutics"},{"issue":"7","key":"r55-20260520","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s40279-021-01450-9","article-title":"An abductive inference approach to assess the performance-enhancing effects of drugs included on the world anti-doping agency prohibited list","volume":"51","author":"Breenfeldt Andersen","year":"2021","journal-title":"Sports Med (Auckl NZ)"},{"issue":"1","key":"r56-20260520","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1389203724666221201093500","article-title":"Thymosin \u03b24 and actin: binding modes, biological functions and clinical applications","volume":"24","author":"Ying","year":"2023","journal-title":"Curr Protein Pept Sci"},{"key":"r57-20260520","doi-asserted-by":"crossref","first-page":"767785","DOI":"10.3389\/fendo.2021.767785","article-title":"Progress on the function and application of thymosin \u03b24","volume":"12","author":"Xing","year":"2021","journal-title":"Front Endocrinol"},{"key":"r58-20260520","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.2010.05492.x","article-title":"Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications","volume":"1194","author":"Crockford","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"r59-20260520","doi-asserted-by":"crossref","first-page":"124033","DOI":"10.1016\/j.jchromb.2024.124033","article-title":"Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS\/MS and their screening by wound healing activities in-vitro","volume":"1235","author":"Rahaman","year":"2024","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"suppl 1","key":"r60-20260520","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1517\/14712598.2015.1011617","article-title":"Advances in the basic and clinical applications of thymosin \u03b24","volume":"15","author":"Goldstein","year":"2015","journal-title":"Expert Opin Biol Ther"},{"issue":"37","key":"r61-20260520","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.2174\/0929867326666190716125456","article-title":"Thymosin \u03b24: a multi-faceted tissue repair stimulating protein in heart injury","volume":"27","author":"Bj\u00f8rklund","year":"2020","journal-title":"Curr Med Chem"},{"issue":"suppl 3","key":"r62-20260520","first-page":"11","article-title":"Peptides and ageing","volume":"23","author":"Khavinson","year":"2002","journal-title":"Neuro Endocrinol Lett"},{"issue":"6","key":"r63-20260520","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3390\/ijms26062691","article-title":"Overview of epitalon-highly bioactive pineal tetrapeptide with promising properties","volume":"26","author":"Araj","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"6","key":"r64-20260520","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s12015-025-10911-x","article-title":"The antioxidant tetrapeptide epitalon enhances delayed wound healing in an in vitro model of diabetic retinopathy","volume":"21","author":"Gatta","year":"2025","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"r65-20260520","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/molecules25030609","article-title":"AEDG peptide (epitalon) stimulates gene expression and protein synthesis during neurogenesis: possible epigenetic mechanism","volume":"25","author":"Khavinson","year":"2020","journal-title":"Molecules"},{"issue":"5","key":"r66-20260520","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s10522-025-10315-x","article-title":"Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity","volume":"26","author":"Al-Dulaimi","year":"2025","journal-title":"Biogerontology"},{"issue":"7","key":"r67-20260520","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.18632\/aging.204007","article-title":"Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro","volume":"14","author":"Yue","year":"2022","journal-title":"Aging"},{"issue":"4","key":"r68-20260520","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1025114230714","article-title":"Effect of epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice","volume":"4","author":"Anisimov","year":"2003","journal-title":"Biogerontology"},{"issue":"12","key":"r69-20260520","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.arthro.2024.04.022","article-title":"Nonoperative and operative soft-tissue, cartilage, and bony regeneration and orthopaedic biologics of the elbow and upper extremity: an orthoregeneration network foundation review","volume":"40","author":"Lazzaretti Fernandes","year":"2024","journal-title":"Arthroscopy"},{"issue":"5","key":"r70-20260520","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/cells8050392","article-title":"Telomere gene therapy: polarizing therapeutic goals for treatment of various diseases","volume":"8","author":"Hong","year":"2019","journal-title":"Cells"},{"issue":"1","key":"r71-20260520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1582-4934.2011.01460.x","article-title":"Pharmaceutical regulation of telomerase and its clinical potential","volume":"16","author":"Sprouse","year":"2012","journal-title":"J Cell Mol Med"},{"issue":"12","key":"r72-20260520","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5435\/JAAOS-D-22-00808","article-title":"Orthobiologics: current status in 2023 and future outlook","volume":"31","author":"Rodeo","year":"2023","journal-title":"J Am Acad Orthop Surg"},{"issue":"4","key":"r73-20260520","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/er.2018-00265","article-title":"The use and abuse of growth hormone in sports","volume":"40","author":"Holt","year":"2019","journal-title":"Endocr Rev"},{"issue":"7","key":"r74-20260520","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1210\/en.2019-00111","article-title":"Actions and potential therapeutic applications of growth hormone-releasing hormone agonists","volume":"160","author":"Schally","year":"2019","journal-title":"Endocrinology"},{"issue":"3","key":"r75-20260520","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4158\/PS-2019-0540","article-title":"Off-label use and misuse of testosterone, growth hormone, thyroid hormone, and adrenal supplements: risks and costs of a growing problem","volume":"26","author":"Irwig","year":"2020","journal-title":"Endocr Pract"},{"issue":"2","key":"r76-20260520","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/joim.13431","article-title":"Performance-enhancing drugs and the Olympics","volume":"291","author":"Watson","year":"2022","journal-title":"J Intern Med"},{"issue":"2","key":"r77-20260520","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1091581820977846","article-title":"Development and regulatory challenges for peptide therapeutics","volume":"40","author":"Zane","year":"2021","journal-title":"Int J Toxicol"},{"issue":"11","key":"r78-20260520","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00228-014-1743-5","article-title":"Identification of black market products and potential doping agents in Germany 2010-2013","volume":"70","author":"Krug","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"43","key":"r79-20260520","doi-asserted-by":"crossref","first-page":"38193","DOI":"10.1021\/acsomega.2c05296","article-title":"Synthetic peptides in doping control: a powerful tool for an analytical challenge","volume":"7","author":"G\u00f3mez-Guerrero","year":"2022","journal-title":"ACS Omega"},{"key":"r80-20260520","doi-asserted-by":"crossref","first-page":"463272","DOI":"10.1016\/j.chroma.2022.463272","article-title":"Multi-analyte screening of small peptides by alkaline pre-activated solid phase extraction coupled with liquid chromatography-high resolution mass spectrometry in doping controls","volume":"1676","author":"Jing","year":"2022","journal-title":"J Chromatogr A"},{"issue":"6","key":"r81-20260520","doi-asserted-by":"crossref","first-page":"e2088","DOI":"10.1210\/clinem\/dgae897","article-title":"Human GH use by athletes with short stature without GH deficiency: therapeutic use exemptions","volume":"110","author":"Allen","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"r82-20260520","doi-asserted-by":"crossref","first-page":"8387271","DOI":"10.1155\/2022\/8387271","article-title":"Dietary supplements as source of unintentional doping","volume":"2022","author":"Kozhuharov","year":"2022","journal-title":"BioMed Res Int"},{"issue":"20","key":"r83-20260520","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.3390\/molecules28207165","article-title":"Peptides as therapeutic agents: challenges and opportunities in the green transition era","volume":"28","author":"Rossino","year":"2023","journal-title":"Molecules"},{"issue":"11","key":"r84-20260520","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3390\/ijms26115131","article-title":"Therapeutic peptides: recent advances in discovery, synthesis, and clinical translation","volume":"26","author":"Zheng","year":"2025","journal-title":"Int J Mol Sci."},{"key":"r85-20260520","doi-asserted-by":"crossref","first-page":"107927","DOI":"10.1016\/j.phrs.2025.107927","article-title":"Glucagon-like peptide-1 receptor agonists and muscle mass effects","volume":"220","author":"Ceasovschih","year":"2025","journal-title":"Pharmacol Res"}],"container-title":["JBJS Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.RVW.26.00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:45:05Z","timestamp":1787751905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.RVW.26.00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":85,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.rvw.26.00027","relation":{},"ISSN":["2329-9185"],"issn-type":[{"value":"2329-9185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}